This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2543 V3 | October 2024

Prescribing information and adverse event reporting statement can be found in the footer

This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2543 V3 | October 2024

Prescribing information and adverse event reporting statement can be found in the footer

This educational and promotional event is organised and funded by Flynn Pharma Ltd.

Intellectual Disabilities and ADHD

Wednesday 11 December 2024 12:30 - 13:30
We are delighted to invite you to join us for our webinar with speaker Dr Sunil Palapaka. He will discuss how to understand intellectual disability and how this differs from learning disability. He will also cover the impact ADHD has on children with intellectual disabilities and review the strategies and solutions to overcome these common challenges.
An account is required to register for this event.

Agenda

12.30
Welcome and introduction, Simon Fitzgerald, Engagement Specialist, Flynn Pharma Ltd
12.35
Intellectual disabilities and ADHD, Dr Sunil Pulapaka, Consultant Child and Adolescent Psychiatrist and Clinical Lead, Neurodevelopmental Service CTM, Cwm Taf Morgannwg Health Board
13.15
Questions and answers
13.30
Close

Meet the Speakers

Dr Sunil Pulapaka
Dr Sunil Pulapaka
Consultant Child and Adolescent Psychiatrist and Clinical Lead, Neurodevelopmental Service CTM, Cwm Taf Morgannwg Health Board

Dr Sunil Pulapaka is an experienced Consultant Child & Adolescent Psychiatrist with 16 years experience in CAMHS. He has been a Member of the Royal College of Psychiatrists since 2005, completing his certificate of training in Child and Adolescent Psychiatry from Greater Glasgow and Clyde and Lanarkshire NHS Trusts.
Working within child and adolescent services he has gained considerable experience in the identification, assessment, and treatment of numerous disorders, including anxiety, depression, OCD, eating disorders and early onset psychosis, as well as attachment and post-traumatic stress disorders and foetal alcohol syndrome. Dr Pulapaka is clinical lead for the neurodevelopmental service, and is responsible for the assessment, diagnosis, and treatment of neurodevelopmental conditions (including ADHD, tic disorders, and ASD). He is trained in 3DI, DISCO and ADOS tools for assessment of ASD.
Dr Pulapaka is a regional advisor for RCPsych CAP faculty, Wales, CASC Examiner for Royal College of Psychiatry, PLAB examiner for the GMC and recruitment lead and educational supervisor for Health Education and Improvement Wales.

What will the webinar cover?

Key learning objectives

  • To understand intellectual disability and how this differs from learning difficulties
  • To discuss the impact ADHD has on children with intellectual disabilities
  • Discussion of the common challenges posed by ADHD in intellectual disability
  • Review the strategies and solutions to overcome common challenges